Endoscopic Treatment Outcomes in Watermelon Stomach Patients with and without Portal Hypertension

Background and Study Aims: Watermelon stomach is a source of recurrent gastrointestinal hemorrhage and anemia. The aims of this study were to describe the endoscopic appearance and treatment outcomes in watermelon stomach patients with and without portal hypertension.
Patients and Methods: All patients with watermelon stomach enrolled in a hemostasis research group’s prospective studies from 1991 to 1999 were identified. Investigators collected data using standardized forms. Comparisons were made using the chi-squared test, Wilcoxon rank-sum test, and Wilcoxon signed-rank test.
Results: Twenty-six of 744 (4 %) consecutively enrolled patients with nonvariceal upper gastrointestinal hemorrhage had watermelon stomach as the cause. Eight of these 26 patients (31 %) also had portal hypertension. These patients had diffuse antral angiomas, as opposed to the classic linear arrays seen in those without portal hypertension. The demographic data and clinical presentations of the two groups were otherwise similar. Palliative endoscopic treatment was associated with a significant rise in hematocrit and a decrease in the need for blood transfusion or hospitalization in watermelon stomach patients with and without portal hypertension.
Conclusions: Watermelon stomach patients with and without portal hypertension had similar clinical presentations. The endoscopic findings differed in that those with portal hypertension had more diffuse gastric angiomas. Bleeding was effectively palliated by endoscopic treatment, regardless of the presence of portal hypertension.

References

• 1 Gretz J E, Achem S R. The watermelon stomach: clinical presentation, diagnosis, and treatment.  Am J Gastroenterol. 1998;  93 890-895
• 2 Park R HR, Russell R I. Watermelon stomach.  Br J Surg. 1991;  78 395-396
• 3 Jabbari M, Cherry R, Lough J O. et al . Gastric antral vascular ectasia: the watermelon stomach.  Gastroenterology. 1984;  87 1165-1170
• 4 Lee F I, Costello F, Flanagan N, Vasudev K S. Diffuse antral vascular ectasia.  Gastrointest Endosc. 1984;  30 88-90
• 5 Kruger R, Ryan M E, Dickson K B, Nunez J F. Diffuse vascular ectasia of the gastric antrum.  Am J Gastroenterol. 1987;  82 421-426
• 6 Gostout C J, Viggiano T R, Ahlquist D A. et al . The clinical and endoscopic spectrum of the watermelon stomach.  J Clin Gastroenterol. 1992;  15 256-263
• 7 Ito M, Uchida Y, Kamono S. et al . Clinical comparisons between two subsets of gastric antral vascular ectasia.  Gastrointest Endosc. 2001;  53 764-770
• 8 Tsai H H, Smith J, Danesh B J. Successful control of bleeding from gastric antral vascular ectasia (watermelon stomach) by laser photocoagulation.  Gut. 1991;  32 93-94
• 9 Sargeant I R, Loizou L A, Rampton D. et al . Laser ablation of upper gastrointestinal vascular ectasias: long term results.  Gut. 1993;  34 470-475
• 10 Liberski S M, McGarrity T J, Hartle R J. et al . The watermelon stomach: long-term outcome in patients treated with Nd:YAG laser therapy.  Gastrointest Endosc. 1994;  40 584-587
• 11 Potamiano S, Carter C R, Anderson J R. Endoscopic laser treatment of diffuse gastric antral vascular ectasia.  Gut. 1994;  35 461-463
• 12 Parente F, Petrillo M, Vago L, Bianchi-Porro G. The watermelon stomach: clinical, endoscopic, endosonographic, and therapeutic aspects in three cases.  Endoscopy. 1995;  27 203-206
• 13 Barnett J L. Vascular ectasia of the gastric antrum.  N Engl J Med. 1998;  339 164-165
• 14 Petrini J L, Johnston J H. Heat probe treatment for antral vascular ectasia.  Gastrointest Endosc. 1989;  35 324-328
• 15 Binmoeller K F, Katon R M. Bipolar electrocoagulation for watermelon stomach.  Gastrointest Endosc. 1990;  36 399-402
• 16 Schuman R W, Rigas B. Bipolar electrocautery as an alternative to Nd:YAG laser for the treatment of the watermelon stomach.  Gastrointest Endosc. 1995;  42 277-278
• 17 Wahab P J, Mulder C JJ, den Hartog G, Thies J E. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences.  Endoscopy. 1997;  29 176-181
• 18 Quintero E, Pique J M, Bombi J A. et al . Gastric mucosal vascular ectasias causing bleeding in cirrhosis: a distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I.  Gastroenterology. 1987;  93 1054-1061
• 19 Viggiano T R, Gostout C J. Portal hypertensive intestinal vasculopathy: a review of the clinical, endoscopic, and histopathologic features.  Am J Gastroenterol. 1992;  87 944-954
• 20 Payen J L, Cales P, Voigt J J. et al . Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis.  Gastroenterology. 1995;  108 138-144
• 21 Spahr L, Villeneuve J P, Dufresne M P. et al . Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension.  Gut. 1999;  44 739-742
• 22 Kamath P S, Lacerda M, Ahlquist D A. et al . Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis.  Gastroenterology. 2000;  118 905-911
• 23 Sarin S K, Shahi H M, Jain M. et al . The natural history of portal hypertensive gastropathy: influence of variceal eradication.  Am J Gastroenterol. 2000;  95 2888-2893
• 24 Yoshikawa I, Murata I, Nakano S, Otsuki M. Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow.  Am J Gastroenterol. 1998;  93 71-74
• 25 Cales P, Zabotto B, Meskens C. et al . Gastroesophageal endoscopic features in cirrhosis: observer variability, interassociations, and relationship to hepatic dysfunction.  Gastroenterology. 1990;  98 156-162
• 26 Randall G M, Jensen D M, Slodownik E, Weinstein W M. Endoscopic biopsy for diagnosis of gastric arteriovenous malformations [abstract].  Gastroenterology. 1987;  92 A 208